Provided by Tiger Trade Technology Pte. Ltd.

Apellis Pharmaceuticals Inc.

21.70
-0.3500-1.59%
Post-market: 21.700.00000.00%19:09 EST
Volume:1.96M
Turnover:42.71M
Market Cap:2.75B
PE:60.59
High:22.55
Open:22.05
Low:21.54
Close:22.05
52wk High:30.48
52wk Low:16.10
Shares:126.53M
Float Shares:78.12M
Volume Ratio:1.03
T/O Rate:2.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3581
EPS(LYR):-1.5970
ROE:14.10%
ROA:5.13%
PB:6.84
PE(LYR):-13.59

Loading ...

Jan 09, 2023

Major Issues Report

8-K - Current report
Jan 05, 2023

Major Issues Report

8-K - Current report
Nov 07, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 24, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2022

Major Issues Report

8-K - Current report
Jul 27, 2022

Major Issues Report

8-K - Current report
Jul 19, 2022

Major Issues Report

8-K - Current report
Jun 02, 2022

Major Issues Report

8-K - Current report
May 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 25, 2022

Major Issues Report

8-K - Current report
Mar 16, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 20, 2022

Major Issues Report

8-K - Current report